This Briefing from Advanced Therapies Week 2023 focusses on how partnerships within the industry can advance research from the clinic to manufacturing scale, to keep pace with the evolving field.
During this session, Terumo’s Stuart Gibb, PhD, Scientific Strategy Lead at Terumo Blood and Cell Technologies, is joined by Nisha C. Durand, PhD, Principal Research Technologist at Mayo Clinic and Matthew M. Hewitt, B.A. PhD, Executive Director, Scientific Services Cell and Gene Therapy at Charles River.
This Briefing was presented at Advanced Therapies Week 2023, in partnership with Terumo.
Lee Buckler, SVP Advanced Therapies, Blood Centers of America, Advanced Therapies Network, reflects on two decades of working within the advanced therapies industry as Phacilitate celebrates 20 years of operating in the field.